AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

CMMB · NASDAQ · Biotechnology

Chemomab Therapeutics (ADR) (CMMB)

Develops nebokitug, a CCL24-neutralizing antibody for fibro-inflammatory diseases.

$2.79

Pre-market+0.02 (+0.72%)

At close$2.77(+1.47%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions15 holders · as of Mar 31, 2026	5.71%	351.6K ADS
Insiders6 holders · as of Sep 1, 2026	8.49%	522.3K ADS
Strategic holders1 holder · as of Aug 13, 2026	6.14%	377.8K ADS
Otherremainder	79.66%	4.90M ADS

6.16M ADS as of Aug 26, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (575.38M in the company's Sep 3, 2026 report, 6.16M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Otto ErikInsider	6.25%	385,000	13Gfiled Feb 10, 2026 ↗
Touchstone Global Investments Pty LtdStrategic	6.14%	377,814	13Gfiled Aug 13, 2026 ↗
Adar1 Capital Management, LLCInstitution	1.30%	80,000 ADS	13Fas of Mar 31, 2026
George Adi MorInsiderdirector, officer: Chief Executive Officer	1.12%	68,809 ADS	Form 4filed Jun 1, 2026 ↗
Citadel Advisors LLCInstitution	1.04%	64,182 ADS	13Fas of Mar 31, 2026
Kestra Private Wealth Services, LLCInstitution	1.00%	61,710 ADS	13Fas of Mar 31, 2026
Ikarian Capital, LLCInstitution	0.84%	51,793 ADS	13Fas of Mar 31, 2026
Neil Harris CohenInsiderdirector	0.54%	33,000 ADS	Form 4filed Sep 1, 2026 ↗
John LawlerInsiderofficer: Chief Development Officer	0.32%	20,000 ADS	Form 4filed Apr 10, 2026 ↗
XTX Topco LtdInstitution	0.30%	18,629 ADS	13Fas of Mar 31, 2026
Rhumbline AdvisersInstitution	0.30%	18,366 ADS	13Fas of Mar 31, 2026
Sigal FatalInsiderofficer: Chief Financial Officer	0.25%	15,222 ADS	Form 4filed Apr 10, 2026 ↗
Smartharvest Portfolios, LLCInstitution	0.24%	14,566 ADS	13Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution	0.22%	13,491 ADS	13Fas of Mar 31, 2026
BNP Paribas Arbitrage, SNCInstitution	0.14%	8,425 ADS	13Fas of Mar 31, 2026
Philadelphia Investment Partners, LLCInstitution	0.13%	8,200 ADS	13Fas of Mar 31, 2026
Gamma Investing LLCInstitution	0.12%	7,579 ADS	13Fas of Mar 31, 2026
Morgan StanleyInstitution	0.07%	4,575 ADS	13Fas of Mar 31, 2026
Nissim DarvishInsiderdirector	0.00%	300 ADS	Form 4filed Apr 10, 2026 ↗
Sbi Securities Co., Ltd.Institution	0.00%	28 ADS	13Fas of Mar 31, 2026
Caitong International Asset Management Co., LtdInstitution	0.00%	8 ADS	13Fas of Mar 31, 2026
UBS Group AGInstitution	0.00%	8 ADS	13Fas of Mar 31, 2026
HBM Healthcare Investments (Cayman) Ltd.Strategic	—12.50% of class, as filed	—	13Dfiled Jul 16, 2026 ↗
Kobi GeorgeInsider	—11.50% of class, as filed	—	13D/Gfiled Jan 20, 2022 ↗
Meitav Dash Investments Ltd.Strategic	—4.87% of class, as filed	—	13D/Gfiled Nov 18, 2019 ↗

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

15 holders · 351.6K shares · 4 new positions · 10 increased · 3 reduced · 3 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Adar1 Capital Management, LLC	80.0K	1.30%	0	May 18, 2026
Citadel Advisors LLC	64.2K	1.04%	−39.6K	May 15, 2026
Kestra Private Wealth Services, LLC	61.7K	1.00%	+10.0K	Apr 20, 2026
Ikarian Capital, LLC	51.8K	0.84%	0	May 15, 2026
XTX Topco Ltd	18.6K	0.30%	−384	May 15, 2026
Rhumbline Advisers	18.4K	0.30%	+510	May 12, 2026
Smartharvest Portfolios, LLC	14.6K	0.24%	+14.6Knew	Apr 21, 2026
Susquehanna International Group, LLP	13.5K	0.22%	+13.5Knew	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
HBM Healthcare Investments (Cayman) Ltd.	12.50%		13D	Jul 16, 2026 ↗
Morgan Stanley	8.40%		13G	Aug 7, 2025 ↗
Otto Erik	6.30%	385.0K	13G	Feb 10, 2026 ↗
Touchstone Global Investments Pty Ltd	5.20%	377.8K	13G	Aug 13, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Aug 28, 2026	Neil Harris Cohendirector	Sale	1,000	$2.80	33,000
Aug 27, 2026	Neil Harris Cohendirector	Sale	1,304	$2.85	34,000
May 29, 2026	George Adi Mordirector, officer: Chief Executive Officer	Purchase · 2 lots	9,804	$2.07	139,131

CongressHouse and Senate disclosures

Not reported.